Cell Signaling Technology

Product Pathways - Protein Translation

Phospho-eEF2 (Thr56) Antibody #2331

eef   eef2   eukaryotic elongation factor 2  

No. Size Price
2331S 100 µl ( 10 western blots ) ¥3,900.00 现货查询 购买询价
2331 carrier free & custom formulation / quantityemail request
Applications Dilution Species-Reactivity Sensitivity MW (kDa) Isotype
W 1:1000 Human,Mouse,Rat,Hamster,Monkey,Chicken, Endogenous 95 Rabbit

Species cross-reactivity is determined by western blot.

Applications Key: W=Western Blotting,

Specificity / Sensitivity

Phospho-eEF2 (Thr56) Antibody detects endogenous levels of eEF2 only when phosphorylated at Thr56. It does not recognize eEF2 phosphorylated at other sites.

Phospho-eEF2 (Thr56) Antibody检测仅在Thr56位点磷酸化的内源性eEF2蛋白水平。该抗体不与在其它位点磷酸化的eEF2蛋白发生交叉反应。

Source / Purification

Polyclonal antibodies are produced by immunizing animals with a synthetic phosphopeptide corresponding to residues surrounding Thr56 of human eEF2. Antibodies are purified by protein A and peptide affinity chromatography.


Western Blotting

Western Blotting

Western blot analysis of extracts from C6 cells, untreated or forskolin-treated (10 µM for 60 minutes), using Phospho-eEF2 (Thr56) Antibody (upper) or eEF2 Antibody #2332 (lower).


Eukaryotic elongation factor 2 (eEF2) catalyzes the translocation of peptidyl-tRNA from the A site to the P site on the ribosome. It has been shown that phosphorylation of eEF2 at threonine 56 by eEF2 kinase inhibits its activity (1-4). eEF2 kinase is normally dependent on Ca2+ ions and calmodulin (5,6). eEF2 kinase can also be activated by PKA in response to elevated cAMP levels (7-9), which are generally increased in stress- or starvation-related conditions. A variety of treatments known to raise intracellular Ca2+ or cAMP levels have been shown to result in increased phosphorylation of eEF2, and thus to inhibit peptide-chain elongation. The inactive phosphorylated eEF2 can be converted to its active nonphosphorylated form by a protein phosphatase, most likely a form of protein phosphatase-2A (PP-2A). Insulin, which activates protein synthesis in a wide range of cell types, induces rapid dephosphorylation of eEF2 through mTOR signaling and may involve modulation of the activity of the PP-2A or the eEF2 kinase or both (10).

真核生物起始延伸因子2 (eEF2)能够促进peptidyl-tRNA从核糖体的A位点转运到P位点。研究显示eEF2激酶可在eEF2蛋白苏氨酸56位点对其磷酸化从而抑制eEF2蛋白的活性(1-4)。eEF2激酶通常是钙离子和钙调蛋白依赖的(5,6)。eEF2激酶也能被响应升高的cAMP水平的PKA所激活(7-9),而cAMP水平的变化通常是由于应激或饥饿相关条件引起的。众所周知,多种处理方法可通过增加细胞内Ca2+或cAMP水平从而增加eEF2的磷酸化,最终抑制多肽链延伸。非活性的磷酸化eEF2能够被磷酸酶转化成具有活性的非磷酸化形式,其中最有可能的磷酸酶是蛋白磷酸酶-2A (PP-2A)。胰岛素能够在广泛的细胞类型中激活蛋白质的合成,且它能诱导eEF2通过mTOR信号通路快速去磷酸化,同时,胰岛素可能涉及到PP-2A或eEF2 kinase活性的调节(10)。

  1. Nairn, A.C. and Palfrey, H.C. (1987) J. Biol. Chem. 262, 17299-17303.
  2. Ryazanov, A.G. et al. (1988) Nature 334, 170-173.
  3. Carlberg, U. et al. (1990) Eur. J. Biochem. 191, 639-645.
  4. Redpath, N.T. et al. (1993) Eur. J. Biochem. 213, 689-699.
  5. Nairn, A.C. et al. (1985) Proc. Natl. Acad. Sci. USA 82, 7939-7943.
  6. Palfrey, H.C. et al. (1987) J. Biol. Chem. 262, 9785-9792.
  7. Redpath, N.T. and Proud, C.G. (1993) Biochem. J. 293, 31-34.
  8. Diggle, T. et al. (1998) Biochem. J. 336, 525-529.
  9. Hovland, R. et al. (1999) FEBS Lett. 444, 97-101.
  10. Proud, C. (2000) Translational Control of Gene Expression. Cold Spring Harbor Laboratory Press, NY, 719-739.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!


Companion Products

For Research Use Only. Not For Use In Diagnostic Procedures.

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.

用户评论 --- 共 0


我要参与评论 :